Clinical Trials Browser

Paraganglioma × anlotinib × Clear all

NCT04860700 2024-06-12

The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma

Phase 2 Completed

Neoplasm Metastasis, Paraganglioma, Paraganglioma, Extra-Adrenal, Pheochromocytoma

NCT05883085 2023-05-31

A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of PPGL

Phase 2 Unknown

Paraganglioma, Pheochromocytoma

NCT05133349 2021-11-24

EASOAIPPGL

Phase 2 Unknown

Paraganglioma, Pheochromocytoma